MY134868A - Improved growth stimulant compositions - Google Patents
Improved growth stimulant compositionsInfo
- Publication number
- MY134868A MY134868A MYPI99004773A MYPI9904773A MY134868A MY 134868 A MY134868 A MY 134868A MY PI99004773 A MYPI99004773 A MY PI99004773A MY PI9904773 A MYPI9904773 A MY PI9904773A MY 134868 A MY134868 A MY 134868A
- Authority
- MY
- Malaysia
- Prior art keywords
- growth stimulant
- improved growth
- release
- improved
- stimulant compositions
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 238000009472 formulation Methods 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 241001494479 Pecora Species 0.000 abstract 1
- 241000282887 Suidae Species 0.000 abstract 1
- FPQFYIAXQDXNOR-QDKLYSGJSA-N alpha-Zearalenol Chemical compound O=C1O[C@@H](C)CCC[C@H](O)CCC\C=C\C2=CC(O)=CC(O)=C21 FPQFYIAXQDXNOR-QDKLYSGJSA-N 0.000 abstract 1
- 229940124325 anabolic agent Drugs 0.000 abstract 1
- 239000003263 anabolic agent Substances 0.000 abstract 1
- 238000013270 controlled release Methods 0.000 abstract 1
- 230000009977 dual effect Effects 0.000 abstract 1
- 239000012729 immediate-release (IR) formulation Substances 0.000 abstract 1
- 239000007943 implant Substances 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 229960002300 zeranol Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
- A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Medicinal Preparation (AREA)
- Fodder In General (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Feed For Specific Animals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
AN IMPROVED WEIGHT AND GROWTH STIMULANT FOR DOMESTICATED ANIMALS SUCH AS CATTLE, PIGS AND SHEEP IS COMPRISED OF AN ANABOLIC AGENT THAT IS SUBCUTANEOUSLY ADMINISTERED IN THE FORM OF A DUAL RELEASE IMPLANT FORMULATION. INCREASED GAINS ARE PARTICULALRY IMPROVED WHEN ZERANOL IS ADMINISTERED IN AN IMMEDIATE-RELEASE AND CONTROLLED-RELEASE FORMULATION WHICH ALLOWS FOR A ONETIME DOSAGE INJECTION.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18594498A | 1998-11-04 | 1998-11-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY134868A true MY134868A (en) | 2007-12-31 |
Family
ID=22683037
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI99004773A MY134868A (en) | 1998-11-04 | 1999-11-03 | Improved growth stimulant compositions |
Country Status (11)
| Country | Link |
|---|---|
| AR (1) | AR025133A1 (en) |
| AU (1) | AU777393B2 (en) |
| BR (2) | BRPI9914996B8 (en) |
| CA (1) | CA2348841C (en) |
| CO (1) | CO5140100A1 (en) |
| CR (1) | CR6351A (en) |
| MY (1) | MY134868A (en) |
| PE (1) | PE20001092A1 (en) |
| TW (1) | TWI250027B (en) |
| WO (1) | WO2000025743A2 (en) |
| ZA (1) | ZA200103494B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020131988A1 (en) * | 1999-12-16 | 2002-09-19 | Foster Todd P. | Pharmaceutical implant containing immediate-release and sustained-release components and method of administration |
| US6953586B1 (en) * | 2000-06-08 | 2005-10-11 | Ivy Animal Health, Inc. | Growth promoting pharmaceutical implant |
| EP4000688B1 (en) | 2020-11-19 | 2025-11-05 | F.I.S.- Fabbrica Italiana Sintetici S.p.A. | Process for the preparation of trenbolone acetate having a definite particle size distribution |
| EP4001289B1 (en) | 2020-11-19 | 2023-05-03 | F.I.S.- Fabbrica Italiana Sintetici S.p.A. | Improved process for the preparation of trenbolone and/or trenbolone acetate |
| EP4001288B1 (en) | 2020-11-19 | 2025-05-07 | F.I.S.- Fabbrica Italiana Sintetici S.p.A. | Process for the preparation of trenbolone acetate having a definite particle size distribution and a irregular hexagon plates crystal habit |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2573307B1 (en) * | 1984-11-22 | 1988-06-10 | Virbac Ctre Rech Biolog | EXTENDED RELEASE ANABOLIZING IMPLANTS |
| US4670249A (en) * | 1985-04-12 | 1987-06-02 | International Minerals & Chemical Corp. | Growth-promoting compositions |
| US5219572A (en) * | 1989-03-17 | 1993-06-15 | Pitman-Moore, Inc. | Controlled release delivery device for macromolecular proteins |
| US5747060A (en) * | 1996-03-26 | 1998-05-05 | Euro-Celtique, S.A. | Prolonged local anesthesia with colchicine |
| US5874098A (en) * | 1997-05-28 | 1999-02-23 | Ivy Laboratories, Inc. | Pellet implant system |
-
1999
- 1999-11-02 CO CO99069032A patent/CO5140100A1/en unknown
- 1999-11-02 WO PCT/US1999/023993 patent/WO2000025743A2/en not_active Ceased
- 1999-11-02 AU AU30967/00A patent/AU777393B2/en not_active Expired
- 1999-11-02 BR BRPI9914996-6 patent/BRPI9914996B8/en unknown
- 1999-11-02 CA CA002348841A patent/CA2348841C/en not_active Expired - Lifetime
- 1999-11-02 TW TW088119044A patent/TWI250027B/en not_active IP Right Cessation
- 1999-11-02 AR ARP990105535A patent/AR025133A1/en active IP Right Grant
- 1999-11-02 BR BR9914996-6A patent/BR9914996A/en not_active IP Right Cessation
- 1999-11-03 PE PE1999001104A patent/PE20001092A1/en not_active IP Right Cessation
- 1999-11-03 MY MYPI99004773A patent/MY134868A/en unknown
-
2001
- 2001-04-20 CR CR6351A patent/CR6351A/en not_active Application Discontinuation
- 2001-04-30 ZA ZA200103494A patent/ZA200103494B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU3096700A (en) | 2000-05-22 |
| CO5140100A1 (en) | 2002-03-22 |
| AU777393B2 (en) | 2004-10-14 |
| BRPI9914996A (en) | 2001-07-10 |
| PE20001092A1 (en) | 2000-10-31 |
| BR9914996A (en) | 2001-07-10 |
| AR025133A1 (en) | 2002-11-13 |
| WO2000025743A2 (en) | 2000-05-11 |
| TWI250027B (en) | 2006-03-01 |
| CA2348841C (en) | 2007-04-17 |
| BRPI9914996B1 (en) | 2011-11-01 |
| WO2000025743A3 (en) | 2000-08-24 |
| ZA200103494B (en) | 2002-07-30 |
| BRPI9914996B8 (en) | 2021-07-06 |
| CR6351A (en) | 2003-11-20 |
| CA2348841A1 (en) | 2000-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0008590A (en) | Polymeric delivery agent, composition, unit dosage form, method for administering a biologically active agent to an animal requiring the agent, method for preparing a composition; it's composed | |
| NZ524138A (en) | Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents | |
| DK0862416T3 (en) | Non-polymeric delayed release administration system | |
| BR0013116B1 (en) | Single dose oral formulations to control ectoparasite infestation in pets, and their use. | |
| BR0014383A (en) | Controlled release compositions comprising nimesulide | |
| EE9900288A (en) | Use of an Oral Pharmaceutical Composition for the manufacture of a medicament for the treatment of erectile dysfunction in men | |
| EP0609345A1 (en) | Biocompatible implant for the timing of ovulation in mares | |
| MY113488A (en) | Compounds with growth hormone releasing properties | |
| SE0002754D0 (en) | New pharmaceutical combination formulation and method of treatment with the combination | |
| ATE396967T1 (en) | (5-(2-HYDROXY-4-CHLOROBENZOYL)VALERIC ACID AND SALTS THEREOF, AND COMPOSITIONS FOR DELIVERING ACTIVE INGREDIENTS CONTAINING THESE COMPOUNDS | |
| NZ514323A (en) | A immunostimulant containing an acitive agent and an adjuvant which increases the effect of the active agent | |
| JP2010500975A (en) | Application of initial amount of LHRH analogue and maintenance amount of LHRH antagonist for treatment of hormone-dependent cancer and corresponding pharmaceutical kit | |
| DE69819145D1 (en) | BIO-DEGRADABLE MICROPARTICLES WITH DELAYED ACTIVE SUBSTANCE RELEASE | |
| MY134868A (en) | Improved growth stimulant compositions | |
| BR9106676A (en) | PEPTIDE, PROCESS TO PROMOTE THE RELEASE OF GROWTH HORMONE LEVELS IN ANIMAL, PHARMACEUTICAL COMPOSITION TO PROMOTE THE RELEASE OF GROWTH HORMONE LEVELS IN ANIMALS, USE OF THE COMPOUND AND PROCESS TO PROMOTE THE LIBERATION IN THE ELEVATION BLOOD | |
| US20010041697A1 (en) | Implant composition containing melengestrol acetate and trenbolone acetate | |
| EP0236002A3 (en) | Pharmaceutical composition comprising a medicament and a water-swellable polymer | |
| RU96103819A (en) | FODDER ADDITIVE FOR YOUNG CATTLE | |
| YU14700A (en) | 8a-azalides as veterinary antimicrobial agents | |
| TH48412A3 (en) | Growth stimulant composition That has been updated | |
| ECSP993205A (en) | IMPROVED GROWTH STIMULATING COMPOSITIONS (CASE AHO948) | |
| UA85060C2 (en) | Bioactive supplement preparation | |
| UY24399A1 (en) | ORAL VETERINARY COMPOSITION CONTAINING AN ANTIBACTERIAL AGENT FLUORQUINOLONO POSSESSING SUPERIOR ABSORBING PROPERTIES AND EXTENDED DURATION OF ANTIMICROBIAL THERAPEUTIC BLOOD LEVELS, AND A METHOD FOR TREATING MICROBIAL INFECTIONS | |
| TH67253A (en) | Dosage of metronomic taxane | |
| BR9612813A (en) | Antibacterial composition of oral veterinary fluoroquinolone for prolonged duration of therapy and method of treatment |